Following the Results of the EMPA-REG OUTCOME Trial With Empagliflozin, Is It Possible to Speak of a Class Effect?

International Journal of General Medicine - New Zealand
doi 10.2147/ijgm.s115566
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa UK Limited


Related search